Language selection

Search

2005-02-16 - Female - 7 Years old

181264

Adverse reaction report number 181264
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2005-02-16
Latest received date 2005-02-16
Age 7 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Other Health Professional
Source of report Community
Report outcome Recovered/resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral15 Milligram every 1 Day(s)2 Month(s)
ADVAIRNOT SPECIFIEDConcomitantUnknown
CODEINE PHOSPHATE SYRUPSYRUPConcomitantUnknown
RISPERDALNOT SPECIFIEDConcomitantUnknown
TYLENOLNOT SPECIFIEDConcomitantUnknown
VENTOLINNOT SPECIFIEDConcomitantUnknown
VITAMINSTABLETConcomitant

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Aggression
Arthralgia
Bone pain
Depression
Epistaxis
Headache
Mania
Pulse abnormal
Pyrexia
Tremor
Date modified: